AI-Designed Drugs: DeepMind’s Clinical Breakthrough

AI Medicine

Isomorphic Labs, DeepMind’s biotech spin-off, is preparing for the first human trials of an AI-designed cancer drug using AlphaFold 3. This marks a turning point for AI in drug discovery and precision medicine.